IRAN DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, and Forecasts (2023 - 2028)

Iran Diabetes Care Devices Market is segmented by Management Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors), and Monitoring Devices (Self-monitoring Blood Glucose, Continuous Glucose Monitoring). The report offers the value (in USD million) for the above segments.

Iran Diabetes Care Devices Industry Overview

IranDevices
Study Period: 2018 - 2028
CAGR: > 5 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Iran Diabetes Care Devices Market Analysis

Iran Diabetes Care Devices Market is expected to register a CAGR greater than 5% over the forecast period, 2022-2027.

The most significant challenges of diabetes care management in developing countries during the COVID-19 pandemic include inadequate preventive measures, interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic care, and a lack of the necessary infrastructure for telehealth services. Diabetes prevalence is increasing in Iran, as it is in many other nations. In addition to the problems inherent with diabetes management in impoverished nations, Iran has encountered new hurdles in the last two years as sanctions have tightened. During the COVID-19 crisis in Iran, the weight of sanctions more than quadrupled.

The most important components of diabetes self-management that should be considered to better control hyperglycemia and prevent or at least delay complications in diabetic patients are regular blood glucose monitoring, following a healthy diet, regular physical activity, and compliance with medication and foot care. Shortages or the high prices of devices such as insulin pens escalated the anxiety of patients with diabetes and complicated the management of their disease during the COVID-19 crisis.

Iran Diabetes Care Devices Industry Segments

Iran Diabetes Care Devices Market is expected to register a CAGR greater than 5% over the forecast period, 2022-2027. Iran Diabetes Care Devices Market is segmented into Management Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors), and Monitoring Devices (Self-monitoring Blood Glucose, Continuous Glucose Monitoring). The report offers the value (in USD million) for the above segments.

Monitoring Devices
Self-monitoring Blood Glucose Devices (Value and Volume, 2016 - 2027)
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring (Value and Volume, 2016 - 2027)
Sensors
Durables
Management Devices
Insulin Pump (Value and Volume, 2016 - 2027)
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes (Value and Volume, 2016 - 2027)
Insulin Cartridges (Value and Volume, 2016 - 2027)
Disposable Pens (Value and Volume, 2016 - 2027)

Report scope can be customized per your requirements. Click here.

Iran Diabetes Care Devices Market Trends

This section covers the major market trends shaping the Iran Diabetes Care Devices Market according to our research experts:

Management Devices Hold Highest Market Share in Iran Diabetes Care Devices Market

Type 1 diabetes (T1D) patients must maintain good lifestyle conditions, which are influenced by a person's personality qualities, social interactions, socioeconomic situations, and environmental living variables. Continuous glucose monitoring (CGM) combined with multiple daily injections (MDI) has been demonstrated to reduce nonsevere and severe hypoglycemia in persons with T1D who are prone to this side event. Patients with T1D who are at high risk of hypoglycemia can employ standalone continuous glucose monitoring to regulate their blood sugar levels even in the terrible living conditions imposed by the COVID-19 pandemic crisis's draconian lockdown.

Diabetes patients in Iran face financial hardship. Pharmacies do not sell enough insulin to diabetics; instead, insulin is sold at a higher price on the open market. Sometimes the parent of a diabetic child is unable to locate insulin. Insulin costs 20-30% of a family's monthly income for children and adults with type 1 diabetes. This does not include the cost of test strips and other supplies, which are extremely costly. Furthermore, insurance companies in Iran are reducing financial support for diabetic treatments. The availability of insulin is restricted, and Iranian families with diabetic children cope by reducing the number of carbohydrates in their child's diet.

Despite all these in Iran usage of Insulin management devices increasing over the years

Iran monitoring Devices

Increasing Type -1 Diabetes Population in Iran

Diabetes is a serious public health concern in Iran, the Middle East's second-largest country, due to its high prevalence rate, growing occurrence rate, and economic impact. It is estimated that by the year 2030, 9.2 million Iranian individuals will have diabetes. Diabetes-related mortality in Iran continues to rise; the age-standardized death rate from diabetes has risen throughout the years. Diabetes has significant economic consequences in the country. Diabetes, in addition to its high direct health-care costs, is a significant risk factor for other chronic illnesses such as cardiovascular disease. Diabetes complications, for example, accounted for USD 412 (49%) of the USD 843 per capita cost of diabetes. Yazd, a world heritage city located in the center of Iran, has one of the highest recorded prevalences of DM in Iran. Other cities in Iran have varying levels of DM awareness. For example, in Kerman, a province south of Yazd, the prevalence of undiagnosed diabetes is only 2.7%, but it is 25% in northern Iran.

Despite the widespread availability of drugs and insulin coverage in Iran, the estimated national control of hyperglycemia, hyperlipidemia, and hypertension (particularly among young men and women) remains inadequate.

As a result, Iran's diabetes care devices market is predicted to expand gradually in the coming years.

Iran Population

Iran Diabetes Care Devices Market Competitor Analysis

The new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market.

Iran Diabetes Care Devices Market Top Players

  1. Medtronic

  2. Roche

  3. NovoNordisk

  4. Abbott

  5. Dexcom

*Disclaimer: Major Players sorted in no particular order

IranDD.png

Iran Diabetes Care Devices Market Recent Developments

  • In Feb 2022, Drug firm Abbott aid it has tied up with various health-tech firms like BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, and Zyla for diabetes care. The company said it has also joined hands with Health, HealthifyMe, and Fitterfly under the initiative.

Iran Diabetes Care Devices Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Industry Attractiveness - Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Monitoring Devices

      1. 5.1.1 Self-monitoring Blood Glucose Devices (Value and Volume, 2016 - 2027)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

      2. 5.1.2 Continuous Blood Glucose Monitoring (Value and Volume, 2016 - 2027)

        1. 5.1.2.1 Sensors

        2. 5.1.2.2 Durables

    2. 5.2 Management Devices

      1. 5.2.1 Insulin Pump (Value and Volume, 2016 - 2027)

        1. 5.2.1.1 Insulin Pump Device

        2. 5.2.1.2 Insulin Pump Reservoir

        3. 5.2.1.3 Infusion Set

      2. 5.2.2 Insulin Syringes (Value and Volume, 2016 - 2027)

      3. 5.2.3 Insulin Cartridges (Value and Volume, 2016 - 2027)

      4. 5.2.4 Disposable Pens (Value and Volume, 2016 - 2027)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016-2027)

    2. 6.2 Type-2 Diabetes population (2016-2027)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Becton and Dickenson

      2. 7.1.2 Medtronic

      3. 7.1.3 Insulet

      4. 7.1.4 Tandem

      5. 7.1.5 Ypsomed

      6. 7.1.6 Novo Nordisk

      7. 7.1.7 Sanofi

      8. 7.1.8 Eli Lilly

      9. 7.1.9 Abbottt

      10. 7.1.10 Roche

      11. 7.1.11 Lifescan (Johnson &Johnson)

      12. 7.1.12 Dexcom

    2. 7.2 Company Share Analysis

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Iran Diabetes Care Devices Market Research FAQs

The Iran Diabetes Care Devices Market is studied from 2018 - 2028.

The Iran Diabetes Care Devices Market is growing at a CAGR of >5% over the next 5 years.

The Iran Diabetes Care Devices Market is valued at 708 Million USD in 2018.

The Iran Diabetes Care Devices Market is valued at 904 Million USD in 2028.

Medtronic, Roche, NovoNordisk, Abbott, Dexcom are the major companies operating in Iran Diabetes Care Devices Market.

Iran Diabetes Care Devices Industry Reports

In-depth industry statistics and market share insights of the Iran Diabetes Care Devices sector for 2020, 2021, and 2022. The Iran Diabetes Care Devices research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Iran Diabetes Care Devices report PDF.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!